Analystreport

Edwards Lifesciences (NYSE: EW) had its price target raised by analysts at Royal Bank of Canada to $145.00. They now have an "outperform" rating on the stock.

Edwards Lifesciences Corporation  (EW) 
Last edwards lifesciences corporation earnings: 4/23 04:15 pm Check Earnings Report
US:NYSE Investor Relations: ir.edwards.com